Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acne Vulgaris
Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.
Atherosclerosis
Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study.
Atherosclerosis
Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.
Atherosclerosis
Replication of calpain-10 genetic association with carotid intima-media thickness.
Atherosclerosis
SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study.
Carcinoma
Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.
Carcinoma
Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma.
Cardiovascular Diseases
Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.
Cardiovascular Diseases
The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
Cataract
Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization.
Cataract
Role of calpains in diabetes mellitus-induced cataractogenesis: a mini review.
Cerebral Small Vessel Diseases
The SNP43 (G/A) polymorphism in CAPN10 gene confers an increased risk of cognitive impairment in cerebral small vessel disease.
Colorectal Neoplasms
Calpain-10 SNP43 and SNP19 polymorphisms and colorectal cancer: a matched case-control study.
Colorectal Neoplasms
Identification of a protective haplogenotype within CAPN10 gene influencing colorectal cancer susceptibility.
Coronary Artery Disease
Association between type 2 diabetes mellitus, biochemical factors and UCSNP-43 polymorphisms of CALPIN-10 gene in patients with atherosclerosis of coronary artery disease in Southern Iran population.
Coronary Artery Disease
Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study.
Cystic Fibrosis
Calpain 10 and development of diabetes mellitus in cystic fibrosis.
Diabetes Mellitus
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.
Diabetes Mellitus
A case-control study on the association of common variants of CAPN10 gene and the risk of type 2 diabetes in an Iranian population.
Diabetes Mellitus
A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes.
Diabetes Mellitus
Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes.
Diabetes Mellitus
Analysis of the structure of calpain-10 and its interaction with the protease inhibitor SNJ-1715.
Diabetes Mellitus
Association of calpain 10 gene polymorphisms with type 2 diabetes mellitus in Southern Indians.
Diabetes Mellitus
Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus.
Diabetes Mellitus
Association of calpain-10 rs2975760 polymorphism with type 2 diabetes mellitus: a meta-analysis.
Diabetes Mellitus
Association of IRS1, CAPN10, and PPARG gene polymorphisms with type 2 diabetes mellitus in the high-risk population of Hyderabad, India.
Diabetes Mellitus
Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population.
Diabetes Mellitus
Calpain 10 and development of diabetes mellitus in cystic fibrosis.
Diabetes Mellitus
Calpain 10 SNP-44 gene polymorphism affects susceptibility to type 2 diabetes mellitus and diabetic-related conditions.
Diabetes Mellitus
Calpain-10 and Adiponectin Gene Polymorphisms in Korean Type 2 Diabetes Patients.
Diabetes Mellitus
Calpain-10 gene polymorphism in type 2 diabetes mellitus patients in the Gaza Strip.
Diabetes Mellitus
Calpain-10 gene polymorphisms and risk of type 2 diabetes mellitus in Mexican mestizos.
Diabetes Mellitus
Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study.
Diabetes Mellitus
Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B.
Diabetes Mellitus
CAPN10 alleles modify laryngeal cancer risk in the Spanish population.
Diabetes Mellitus
CAPN10 SNP43 G>A gene polymorphism and type 2 diabetes mellitus in the Asian population: a meta-analysis of 9353 participants.
Diabetes Mellitus
Capn10, a candidate gene responsible for type 2 diabetes mellitus in the OLETF rat.
Diabetes Mellitus
Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization.
Diabetes Mellitus
Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women.
Diabetes Mellitus
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.
Diabetes Mellitus
Haplotype association of calpain 10 gene variants with type 2 diabetes mellitus in an Irish sample.
Diabetes Mellitus
Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population.
Diabetes Mellitus
Investigation of glucocorticoid receptor and calpain-10 gene polymorphisms in Turkish patients with type 2 diabetes mellitus
Diabetes Mellitus
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells.
Diabetes Mellitus
Role of Calpain-10 in the Development of Diabetes Mellitus and Its Complications.
Diabetes Mellitus
Single Nucleotide Polymorphisms Associated with Metformin and Sulphonylureas' Glycaemic Response among South African Adults with Type 2 Diabetes Mellitus.
Diabetes Mellitus
Single nucleotide polymorphisms in CAPN10 gene of Chinese people and its correlation with type 2 diabetes mellitus in Han people of northern China.
Diabetes Mellitus
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom.
Diabetes Mellitus
The effect of calpain-10 gene polymorphism on the development of type 2 diabetes mellitus in a Turkish population.
Diabetes Mellitus
The reduction of Calpain-10 expression is associated with risk polymorphisms in obese children.
Diabetes Mellitus
Type 2 diabetes candidate gene CAPN10: first, but not last.
Diabetes Mellitus
Variants of calpain-10 gene and its association with type 2 diabetes mellitus in a Chinese population.
Diabetes Mellitus
Variation in the calpain-10 gene is not associated with gestational diabetes mellitus.
Diabetes Mellitus
Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population.
Diabetes Mellitus
[Association analysis of SNP-63 and indel-19 variant in the calpain-10 gene with polycystic ovary syndrome in women of reproductive age].
Diabetes Mellitus
[Association between calpain-10 gene polymorphism and risk of type 2 diabetes mellitus: a meta analysis]
Diabetes Mellitus
[Association of the calpain-10 gene polymorphism with glucose metabolism disorder in pregnant women]
Diabetes Mellitus
[Single nucleotide polymorphisms in CAPN10 gene of Chinese population and its correlation with type 2 diabetes mellitus in Han people of northern China]
Diabetes Mellitus
[SNP-19 genotypic variants of CAPN10 gene and its relation to diabetes mellitus type 2 in a population of Ciudad Juarez, Mexico].
Diabetes Mellitus
[The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits]
Diabetes Mellitus
[The UCSNP44 variation of calpain 10 gene on NIDDM1 locus and its impact on plasma glucose levels in type 2 diabetic patients]
Diabetes Mellitus, Type 2
A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin.
Diabetes Mellitus, Type 2
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.
Diabetes Mellitus, Type 2
A case-control study on the association of common variants of CAPN10 gene and the risk of type 2 diabetes in an Iranian population.
Diabetes Mellitus, Type 2
A genetic variant of the CAPN10 gene in Mexican subjects with dyslipidemia is associated with increased HDL-cholesterol concentrations after the consumption of a soy protein and soluble fiber dietary portfolio.
Diabetes Mellitus, Type 2
A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes.
Diabetes Mellitus, Type 2
A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
A Replication Study of the IRS1, CAPN10, TCF7L2, and PPARG Gene Polymorphisms Associated with Type 2 Diabetes in Two Different Populations of Mexico.
Diabetes Mellitus, Type 2
Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree.
Diabetes Mellitus, Type 2
Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes.
Diabetes Mellitus, Type 2
Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies.
Diabetes Mellitus, Type 2
Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes.
Diabetes Mellitus, Type 2
Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies.
Diabetes Mellitus, Type 2
Association of calpain 10 gene polymorphisms with type 2 diabetes mellitus in Southern Indians.
Diabetes Mellitus, Type 2
Association of calpain-10 polymorphisms with type 2 diabetes in the Tunisian population.
Diabetes Mellitus, Type 2
Association of calpain-10 rs2975760 polymorphism with type 2 diabetes mellitus: a meta-analysis.
Diabetes Mellitus, Type 2
Association of IRS1, CAPN10, and PPARG gene polymorphisms with type 2 diabetes mellitus in the high-risk population of Hyderabad, India.
Diabetes Mellitus, Type 2
Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses.
Diabetes Mellitus, Type 2
Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population.
Diabetes Mellitus, Type 2
Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study.
Diabetes Mellitus, Type 2
Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese.
Diabetes Mellitus, Type 2
Association of two synonymous splicing-associated CpG single nucleotide polymorphisms in calpain 10 and solute carrier family 2 member 2 with type 2 diabetes.
Diabetes Mellitus, Type 2
Calpain 10 and genetics of type 2 diabetes.
Diabetes Mellitus, Type 2
Calpain 10 and type 2 diabetes: are we getting closer to an explanation?
Diabetes Mellitus, Type 2
Calpain 10 as a predictive gene for type 2 diabetes: evidence from a novel screening system using white blood cells of Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Diabetes Mellitus, Type 2
Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese.
Diabetes Mellitus, Type 2
Calpain 10 Homology Modeling with CYGAK and Increased Lipophilicity Leads to Greater Potency and Efficacy in Cells.
Diabetes Mellitus, Type 2
Calpain 10 SNP-44 gene polymorphism affects susceptibility to type 2 diabetes mellitus and diabetic-related conditions.
Diabetes Mellitus, Type 2
Calpain Activity in Leukocytes Is Associated with Diabetes Biochemical Markers.
Diabetes Mellitus, Type 2
Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes.
Diabetes Mellitus, Type 2
Calpain inhibition and insulin action in cultured human muscle cells.
Diabetes Mellitus, Type 2
Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling.
Diabetes Mellitus, Type 2
Calpain-10 (NIDDM1) as a Susceptibility Gene for Common Type 2 Diabetes.
Diabetes Mellitus, Type 2
Calpain-10 and Adiponectin Gene Polymorphisms in Korean Type 2 Diabetes Patients.
Diabetes Mellitus, Type 2
Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Calpain-10 gene and protein expression in human skeletal muscle: effect of acute lipid-induced insulin resistance and type 2 diabetes.
Diabetes Mellitus, Type 2
Calpain-10 gene polymorphism in type 2 diabetes mellitus patients in the Gaza Strip.
Diabetes Mellitus, Type 2
Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells.
Diabetes Mellitus, Type 2
Calpain-10 gene polymorphisms and risk of type 2 diabetes mellitus in Mexican mestizos.
Diabetes Mellitus, Type 2
Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study.
Diabetes Mellitus, Type 2
Calpain-10 gene polymorphisms in type 2 diabetes and its micro- and macrovascular complications.
Diabetes Mellitus, Type 2
Calpain-10 haplotype combination and association with gestational diabetes mellitus.
Diabetes Mellitus, Type 2
Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndrome.
Diabetes Mellitus, Type 2
Calpain-10 is a component of the obesity-related quantitative trait locus Adip1.
Diabetes Mellitus, Type 2
Calpain-10 is a component of the obesity-related quantitative trait locus, Adip1.
Diabetes Mellitus, Type 2
Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B.
Diabetes Mellitus, Type 2
Calpain-10: from genome search to function.
Diabetes Mellitus, Type 2
Calpain: a death protein that mediates progression of liver injury.
Diabetes Mellitus, Type 2
Calpains and human disease.
Diabetes Mellitus, Type 2
Calpains play a role in insulin secretion and action.
Diabetes Mellitus, Type 2
CAPN10 alleles modify laryngeal cancer risk in the Spanish population.
Diabetes Mellitus, Type 2
CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes.
Diabetes Mellitus, Type 2
CAPN10 SNP43 G>A gene polymorphism and type 2 diabetes mellitus in the Asian population: a meta-analysis of 9353 participants.
Diabetes Mellitus, Type 2
Capn10, a candidate gene responsible for type 2 diabetes mellitus in the OLETF rat.
Diabetes Mellitus, Type 2
Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene.
Diabetes Mellitus, Type 2
Challenges in studies of the genetic basis of Type 2 diabetes.
Diabetes Mellitus, Type 2
Characterization of endogenous and recombinant human calpain-10.
Diabetes Mellitus, Type 2
Characterization of GLUT4 and calpain expression in healthy human skeletal muscle during fasting and refeeding.
Diabetes Mellitus, Type 2
Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury.
Diabetes Mellitus, Type 2
Co-existence of risk and protective haplotypes of Calpain 10 gene to type 2 diabetes in the eastern Indian population.
Diabetes Mellitus, Type 2
Combining sperm typing and linkage disequilibrium analyses reveals differences in selective pressures or recombination rates across human populations.
Diabetes Mellitus, Type 2
Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women.
Diabetes Mellitus, Type 2
Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.
Diabetes Mellitus, Type 2
Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.
Diabetes Mellitus, Type 2
Ethnic differences in CAPN10 SNP-19 in type 2 diabetes: a North-West Indian case control study and evidence from meta-analysis.
Diabetes Mellitus, Type 2
Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells.
Diabetes Mellitus, Type 2
Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans.
Diabetes Mellitus, Type 2
Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle.
Diabetes Mellitus, Type 2
Genetic determinants of type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population.
Diabetes Mellitus, Type 2
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese.
Diabetes Mellitus, Type 2
Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus.
Diabetes Mellitus, Type 2
GLUT4 expression in 3T3-L1 adipocytes is repressed by proteasome inhibition, but not by inhibition of calpains.
Diabetes Mellitus, Type 2
GSTT1, Calpain 10 SNP 19 and indices of glycaemia in type 2 diabetes.
Diabetes Mellitus, Type 2
Haplotype association of calpain 10 gene variants with type 2 diabetes mellitus in an Irish sample.
Diabetes Mellitus, Type 2
Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes.
Diabetes Mellitus, Type 2
Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians.
Diabetes Mellitus, Type 2
Haplotype structure and phylogenetic shadowing of a hypervariable region in the CAPN10 gene.
Diabetes Mellitus, Type 2
Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population.
Diabetes Mellitus, Type 2
Identification of copy number variation of CAPN10 in Thais with type 2 diabetes by multiplex PCR and denaturing high performance liquid chromatography (DHPLC).
Diabetes Mellitus, Type 2
Impaired insulin secretion in transgenic mice over-expressing calpastatin in pancreatic ?-cells.
Diabetes Mellitus, Type 2
Investigation of glucocorticoid receptor and calpain-10 gene polymorphisms in Turkish patients with type 2 diabetes mellitus
Diabetes Mellitus, Type 2
LightCycler assay in the analysis of haplotypes of the type 2 diabetes susceptibility gene CAPN10.
Diabetes Mellitus, Type 2
Linkage but not association of calpain-10 to type 2 diabetes replicated in northern sweden.
Diabetes Mellitus, Type 2
Linkage of calpain 10 to type 2 diabetes: the biological rationale.
Diabetes Mellitus, Type 2
Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.
Diabetes Mellitus, Type 2
Molecular signatures of Calpain 10 isoforms sequences, envisage functional similarity and therapeutic potential.
Diabetes Mellitus, Type 2
New evidence for the role of calpain 10 in autosomal recessive intellectual disability: identification of two novel nonsense variants by exome sequencing in Iranian families.
Diabetes Mellitus, Type 2
No evidence for involvement of the calpain-10 gene 'high-risk' haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity.
Diabetes Mellitus, Type 2
Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes.
Diabetes Mellitus, Type 2
Patterns of linkage disequilibrium in the type 2 diabetes gene calpain-10.
Diabetes Mellitus, Type 2
Population genetics of CAPN10 and GPR35: implications for the evolution of type 2 diabetes variants.
Diabetes Mellitus, Type 2
Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification.
Diabetes Mellitus, Type 2
Relationship between calpain-10 gene polymorphism and insulin resistance phenotypes in Chinese.
Diabetes Mellitus, Type 2
Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.
Diabetes Mellitus, Type 2
Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians.
Diabetes Mellitus, Type 2
Role of Calpain-10 in the Development of Diabetes Mellitus and Its Complications.
Diabetes Mellitus, Type 2
RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets.
Diabetes Mellitus, Type 2
Searching for genes in diabetes and the metabolic syndrome.
Diabetes Mellitus, Type 2
Single nucleotide polymorphisms in CAPN10 gene of Chinese people and its correlation with type 2 diabetes mellitus in Han people of northern China.
Diabetes Mellitus, Type 2
SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study.
Diabetes Mellitus, Type 2
SNPHunter: a bioinformatic software for single nucleotide polymorphism data acquisition and management.
Diabetes Mellitus, Type 2
Structure, activation, and biology of calpain.
Diabetes Mellitus, Type 2
Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom.
Diabetes Mellitus, Type 2
Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells.
Diabetes Mellitus, Type 2
The activity of calpains in lymphocytes is glucose-dependent and is decreased in diabetic patients.
Diabetes Mellitus, Type 2
The calpain family and human disease.
Diabetes Mellitus, Type 2
The calpain system and diabetes.
Diabetes Mellitus, Type 2
The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
Diabetes Mellitus, Type 2
The effect of calpain-10 gene polymorphism on the development of type 2 diabetes mellitus in a Turkish population.
Diabetes Mellitus, Type 2
The reduction of Calpain-10 expression is associated with risk polymorphisms in obese children.
Diabetes Mellitus, Type 2
The Uyghur population and genetic susceptibility to type 2 diabetes: potential role for variants in CAPN10, APM1 and FUT6 genes.
Diabetes Mellitus, Type 2
Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association.
Diabetes Mellitus, Type 2
Type 2 diabetes candidate gene CAPN10: first, but not last.
Diabetes Mellitus, Type 2
Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels.
Diabetes Mellitus, Type 2
Variants of calpain-10 gene and its association with type 2 diabetes mellitus in a Chinese population.
Diabetes Mellitus, Type 2
Variants within the calpain-10 gene and relationships with type 2 diabetes (T2DM) and T2DM-related traits among Tunisian Arabs.
Diabetes Mellitus, Type 2
Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians.
Diabetes Mellitus, Type 2
Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: studies in 6018 whites.
Diabetes Mellitus, Type 2
Variation in the calpain-10 gene affects blood glucose levels in the British population.
Diabetes Mellitus, Type 2
Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.
Diabetes Mellitus, Type 2
Variation in the calpain-10 gene is not associated with gestational diabetes mellitus.
Diabetes Mellitus, Type 2
Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort.
Diabetes Mellitus, Type 2
Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome.
Diabetes Mellitus, Type 2
Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population.
Diabetes Mellitus, Type 2
[Association analysis of SNP-63 and indel-19 variant in the calpain-10 gene with polycystic ovary syndrome in women of reproductive age].
Diabetes Mellitus, Type 2
[Association between calpain-10 gene polymorphism and risk of type 2 diabetes mellitus: a meta analysis]
Diabetes Mellitus, Type 2
[Calpain 10 as a susceptibility gene of type 2 diabetes]
Diabetes Mellitus, Type 2
[Calpain and pathology in view of structure-function relationships]
Diabetes Mellitus, Type 2
[Diabetes mellitus]
Diabetes Mellitus, Type 2
[Effect of the Gly972Arg, SNP43 and Prol2Ala polymorphisms of the genes IRS1, CAPN10 and PPARG2 on secondary failure to sulphonylurea and metformin in patients with type 2 diabetes in Yucatán, México]
Diabetes Mellitus, Type 2
[Perspectives on postgenome medicine: Gene therapy for diabetes mellitus]
Diabetes Mellitus, Type 2
[Single nucleotide polymorphisms in CAPN10 gene of Chinese population and its correlation with type 2 diabetes mellitus in Han people of northern China]
Diabetes Mellitus, Type 2
[Study of association of the SNP19 polymorphism of calpain 10 gene with type 2 diabetes in ethnic sub-groups of the Tunisian population: gene-environment interaction]
Diabetes Mellitus, Type 2
[Study on Calpain10 gene polymorphism in Chinese type 2 diabetes families]
Diabetes Mellitus, Type 2
[The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits]
Diabetes Mellitus, Type 2
[The UCSNP44 variation of calpain 10 gene on NIDDM1 locus and its impact on plasma glucose levels in type 2 diabetic patients]
Diabetes Mellitus, Type 2
[Type 2 diabetes and genetic variations of calpain 10 gene]
Diabetes, Gestational
ADCY5, CAPN10 and JAZF1 Gene Polymorphisms and Placental Expression in Women with Gestational Diabetes.
Diabetes, Gestational
Association analysis of calpain 10 gene variants/haplotypes with gestational diabetes mellitus among Mexican women.
Diabetes, Gestational
Calpain-10 haplotype combination and association with gestational diabetes mellitus.
Diabetes, Gestational
Investigation of Calpain 10 (rs2975760) gene polymorphism in Asian Indians with Gestational Diabetes Mellitus.
Diabetes, Gestational
Meta-analysis of the association between four CAPN10 gene variants and gestational diabetes mellitus.
Diabetes, Gestational
TCF7L2, CAPN10 polymorphisms are associated with gestational diabetes mellitus (GDM) risks: a meta-analysis.
Diabetes, Gestational
The Association Between the rs2975760 and rs3792267 Single Nucleotide Polymorphisms of Calpain 10 (CAPN10) and Gestational Diabetes Mellitus.
Diabetes, Gestational
Variation in the calpain-10 gene is not associated with gestational diabetes mellitus.
Diabetes, Gestational
[Single-nucleotide polymorphisms and genotype combinations in calpain-10 gene of gestational diabetes mellitus]
Diabetic Nephropathies
Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy.
Diabetic Nephropathies
Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia.
Diabetic Retinopathy
Calpain 10 SNP-44 gene polymorphism affects susceptibility to type 2 diabetes mellitus and diabetic-related conditions.
Dyslipidemias
A genetic variant of the CAPN10 gene in Mexican subjects with dyslipidemia is associated with increased HDL-cholesterol concentrations after the consumption of a soy protein and soluble fiber dietary portfolio.
Esophageal Squamous Cell Carcinoma
Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma.
Glucose Intolerance
Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes.
Glucose Intolerance
Association of CAPN10 gene with insulin sensitivity, glucose tolerance and renal function in essential hypertensive patients.
Glucose Intolerance
Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese.
Glucose Intolerance
Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians.
Glucose Metabolism Disorders
[Association of the calpain-10 gene polymorphism with glucose metabolism disorder in pregnant women]
Hirsutism
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.
Hirsutism
CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome.
Hirsutism
Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism.
Hirsutism
Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
Hyperandrogenism
Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
Hypercholesterolemia
Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.
Hypercholesterolemia
Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
Hyperglycemia
Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia.
Hyperinsulinism
Calpain-10 gene and protein expression in human skeletal muscle: effect of acute lipid-induced insulin resistance and type 2 diabetes.
Hyperinsulinism
[Association analysis of SNP-63 and indel-19 variant in the calpain-10 gene with polycystic ovary syndrome in women of reproductive age].
Hypertension
Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model.
Hypertension
Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.
Hypertension
Replication of calpain-10 genetic association with carotid intima-media thickness.
Hypertension
Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population.
Hypertension
[Relationship between calpain-10 gene polymorphism, hypertension and plasma glucose]
Infertility
Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
Insulin Resistance
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.
Insulin Resistance
A genetic variant of the CAPN10 gene in Mexican subjects with dyslipidemia is associated with increased HDL-cholesterol concentrations after the consumption of a soy protein and soluble fiber dietary portfolio.
Insulin Resistance
Association analysis of calpain 10 gene variants/haplotypes with gestational diabetes mellitus among Mexican women.
Insulin Resistance
Association of calpain-10 gene with microvascular function.
Insulin Resistance
Association of CAPN10 gene with insulin sensitivity, glucose tolerance and renal function in essential hypertensive patients.
Insulin Resistance
Association of the diabetes gene calpain-10 with subclinical atherosclerosis: the Mexican-American Coronary Artery Disease Study.
Insulin Resistance
Calpain inhibition and insulin action in cultured human muscle cells.
Insulin Resistance
Calpain-10 and Adiponectin Gene Polymorphisms in Korean Type 2 Diabetes Patients.
Insulin Resistance
Calpain-10 gene and protein expression in human skeletal muscle: effect of acute lipid-induced insulin resistance and type 2 diabetes.
Insulin Resistance
Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells.
Insulin Resistance
Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndrome.
Insulin Resistance
Calpain-10: from genome search to function.
Insulin Resistance
Characterization of GLUT4 and calpain expression in healthy human skeletal muscle during fasting and refeeding.
Insulin Resistance
Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism.
Insulin Resistance
Coordinated control of both insulin secretion and insulin action through calpain-10-mediated regulation of exocytosis?
Insulin Resistance
Genetic and environmental aspect of polycystic ovary syndrome.
Insulin Resistance
Genetics of type 2 diabetes and insulin resistance: knowledge from human studies.
Insulin Resistance
Insulin sensitivity of glucose disposal and lipolysis: no influence of common genetic variants in IRS-1 and CAPN10.
Insulin Resistance
Metabolic syndrome: evidences for a personalized nutrition.
Insulin Resistance
Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes.
Insulin Resistance
Reduced skeletal muscle calpain-10 transcript level is due to a cumulative decrease in major isoforms.
Insulin Resistance
Relationship between calpain-10 gene polymorphism and insulin resistance phenotypes in Chinese.
Insulin Resistance
Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians.
Insulin Resistance
Targeted suppression of calpain-10 expression impairs insulin-stimulated glucose uptake in cultured primary human skeletal muscle cells.
Insulin Resistance
The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
Insulin Resistance
Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels.
Insulin Resistance
Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians.
Insulin Resistance
Variation in the calpain-10 gene affects blood glucose levels in the British population.
Insulin Resistance
Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population.
Insulin Resistance
[Association analysis of SNP-63 and indel-19 variant in the calpain-10 gene with polycystic ovary syndrome in women of reproductive age].
Intellectual Disability
New evidence for the role of calpain 10 in autosomal recessive intellectual disability: identification of two novel nonsense variants by exome sequencing in Iranian families.
Ischemic Stroke
Calpain 10 gene polymorphisms and the risk of ischaemic stroke in a Polish population.
Ischemic Stroke
Correlation between Calpain-10 single-nucleotide polymorphisms and obstructive sleep apnea/hypopnoea syndrome with ischemic stroke in a Chinese population: A population-based study.
Laryngeal Neoplasms
Calpain 10 gene and laryngeal cancer: A survival analysis.
Laryngeal Neoplasms
CAPN10 alleles modify laryngeal cancer risk in the Spanish population.
Lung Neoplasms
Association of Diabetes Susceptibility Gene Calpain-10 with Pancreatic Cancer Among Smokers.
Melanoma
Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and ?-catenin pathways.
Metabolic Syndrome
A genetic variant of the CAPN10 gene in Mexican subjects with dyslipidemia is associated with increased HDL-cholesterol concentrations after the consumption of a soy protein and soluble fiber dietary portfolio.
Metabolic Syndrome
Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndrome.
Metabolic Syndrome
CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome.
Metabolic Syndrome
Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes.
Metabolic Syndrome
Metabolic syndrome: evidences for a personalized nutrition.
Metabolic Syndrome
The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
Metabolic Syndrome
Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.
Muscular Dystrophies
Calpain-related diseases.
Muscular Dystrophies, Limb-Girdle
Calpain-related diseases.
Myocardial Infarction
Analysis of the structure of calpain-10 and its interaction with the protease inhibitor SNJ-1715.
Neoplasm Metastasis
Differential gene expression analysis for osteosarcoma lung metastases.
Neoplasms
Analysis of the structure of calpain-10 and its interaction with the protease inhibitor SNJ-1715.
Neoplasms
Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
Neoplasms
The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination.
Neoplasms
The positive is inside the negative: HER2-negative tumors can express the HER2 intracellular domain and present a HER2-positive phenotype.
Obesity
Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese.
Obesity
Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells.
Obesity
Calpain-10 is a component of the obesity-related quantitative trait locus Adip1.
Obesity
Calpain-10 is a component of the obesity-related quantitative trait locus, Adip1.
Obesity
Genetic association studies of obesity in Africa: a systematic review.
Obesity
No evidence for involvement of the calpain-10 gene 'high-risk' haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity.
Obesity
Obesity and developmental delay in a patient with uniparental disomy of chromosome 2.
Obesity
Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: studies in 6018 whites.
Obesity
Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.
Obesity, Abdominal
Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.
Pancreatic Neoplasms
Association of Diabetes Susceptibility Gene Calpain-10 with Pancreatic Cancer Among Smokers.
Polycystic Ovary Syndrome
111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women.
Polycystic Ovary Syndrome
Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.
Polycystic Ovary Syndrome
Association of CAPN10 SNPs and Haplotypes with Polycystic Ovary Syndrome among South Indian Women.
Polycystic Ovary Syndrome
Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: A meta-analysis and meta-regression.
Polycystic Ovary Syndrome
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.
Polycystic Ovary Syndrome
Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.
Polycystic Ovary Syndrome
CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome.
Polycystic Ovary Syndrome
Comment: CAPN10 alleles are associated with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Comments on the latest meta-analysis of CAPN10 polymorphism associations with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Common polymorphisms of calpain-10 and the risk of polycystic ovary syndrome in Tunisian population: a case-control study.
Polycystic Ovary Syndrome
Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.
Polycystic Ovary Syndrome
Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.
Polycystic Ovary Syndrome
Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients.
Polycystic Ovary Syndrome
The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
Polycystic Ovary Syndrome
Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome.
Polycystic Ovary Syndrome
[Association analysis of SNP-63 and indel-19 variant in the calpain-10 gene with polycystic ovary syndrome in women of reproductive age].
Polycystic Ovary Syndrome
[Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients]
Pre-Eclampsia
Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia.
Retinal Degeneration
Involvement of calpain isoforms in retinal degeneration in WBN/Kob rats.
Sleep Apnea, Obstructive
Correlation between Calpain-10 single-nucleotide polymorphisms and obstructive sleep apnea/hypopnoea syndrome with ischemic stroke in a Chinese population: A population-based study.
Stomach Neoplasms
The calpain family and human disease.
Stomach Neoplasms
The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination.
Stroke
Analysis of the structure of calpain-10 and its interaction with the protease inhibitor SNJ-1715.
Stroke
Calpain 10 gene polymorphisms and the risk of ischaemic stroke in a Polish population.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M.C.; Estreicher, A.; Gasteiger, E.; Martin M.J.; Michoud, K.; O'Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M.
The SWISS-PROT protein knowledgebase and its supplement TrEMBL
Nucleic Acids Res.
31
365-370
2003
Homo sapiens (Q9HC96), Macaca fascicularis (Q95LP4), Mus musculus (Q9ESK3), Mus musculus 129/SvJ (Q9ESK3), Rattus norvegicus (Q9ES66)
brenda
Strausberg R.L.; Feingold E.A.; Grouse L.H.; Derge J.G.; et al.
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences
Proc. Natl. Acad. Sci. USA
99
16899-16903
2002
Homo sapiens (Q9HC96), Mus musculus (Q9ESK3)
brenda
Horikawa, Y.; Oda, N.; Cox, N.J.; Li, X.; et al.
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Nat. Genet.
26
163-75
2000
Mus musculus (Q9ESK3), Homo sapiens (Q9HC96)
brenda
Nagase, T.; Nakayama, M.; Nakajima, D.; Kikuno, R.; Ohara, O.
Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro
DNA Res.
8
85-95
2001
Homo sapiens (Q9HC96)
brenda
Ma, H.; Fukiage, C.; Kim, Y.H.; Duncan, M.K.; Reed, N.E.
Sih, M.; Azuma, M.; Shearer, T.R.: Characterization and expression of calpain 10. A novel ubiquitous calpain within nuclear localization
J. Biol. Chem.
276
28525-28531
2001
Homo sapiens, Mus musculus, Rattus norvegicus (Q9ES66)
brenda
Carlsson, E.; Poulsen, P.; Storgaard, H.; Almgren, P.; Ling, C.; Jensen, C.B.; Madsbad, S.; Groop, L.; Vaag, A.; Ridderstrale, M.
Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle
Diabetes
54
3015-3020
2005
Homo sapiens (Q9HC96)
brenda
Turner, M.D.; Cassell, P.G.; Hitman, G.A.
Calpain-10: from genome search to function
Diabetes Metab. Res. Rev.
21
505-514
2005
Homo sapiens (Q9HC96)
brenda
Marshall, C.; Hitman, G.A.; Partridge, C.J.; Clark, A.; Ma, H.; Shearer, T.R.; Turner, M.D.
Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells
Mol. Endocrinol.
19
213-224
2005
Homo sapiens (Q9HC96)
brenda
Vollmert, C.; Hahn, S.; Lamina, C.; Huth, C.; Kolz, M.; Schoepfer-Wendels, A.; Mann, K.; Bongardt, F.; Mueller, J.C.; Kronenberg, F.; Wichmann, H.E.; Herder, C.; Holle, R.; Loewel, H.; Illig, T.; Janssen, O.E.; Janssen, O.E.
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians
Am. J. Physiol. Endocrinol. Metab.
292
E836-E844
2007
Homo sapiens
brenda
Lopez-Orduna, E.; Garcia-Mena, J.; Garcia-Macedo, R.; Stumvoll, M.; Cruz, M.
CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes
Biochem. Biophys. Res. Commun.
358
831-836
2007
Homo sapiens (Q9HC96), Homo sapiens
brenda
Norton, L.; Parr, T.; Chokkalingam, K.; Bardsley, R.G.; Ye, H.; Bell, G.I.; Pelsers, M.M.; van Loon, L.J.; Tsintzas, K.
Calpain-10 gene and protein expression in human skeletal muscle: effect of acute lipid-induced insulin resistance and type 2 diabetes
J. Clin. Endocrinol. Metab.
93
992-998
2008
Homo sapiens
brenda
Covington, M.D.; Arrington, D.D.; Schnellmann, R.G.
Calpain 10 is required for cell viability and is decreased in the aging kidney
Am. J. Physiol. Renal Physiol.
296
F478-F486
2009
Homo sapiens, Mus musculus, Rattus norvegicus
brenda
Dong, B.; Liu, R.
Characterization of endogenous and recombinant human calpain-10
Biochimie
90
1362-1371
2008
Homo sapiens
brenda
Lee, J.Y.; Lee, W.J.; Hur, S.E.; Lee, C.M.; Sung, Y.A.; Chung, H.W.
111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women
Fertil. Steril.
92
830-833
2008
Homo sapiens
brenda
Ezzidi, I.; Turki, A.; Messaoudi, S.; Chaieb, M.; Kacem, M.; Al-Khateeb, G.M.; Mahjoub, T.; Almawi, W.Y.; Mtiraoui, N.
Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study
BMC Med. genet.
11
75
2010
Homo sapiens
brenda
Zhou, X.; Wang, Y.; Zhang, Y.; Gao, P.; Zhu, D.
Association of CAPN10 gene with insulin sensitivity, glucose tolerance and renal function in essential hypertensive patients
Clin. Chim. Acta
411
1126-1131
2010
Homo sapiens
brenda
Adak, S.; Sengupta, S.; Chowdhury, S.; Bhattacharyya, M.
Co-existence of risk and protective haplotypes of Calpain 10 gene to type 2 diabetes in the eastern Indian population
Diab. Vasc. Dis. Res.
7
63-68
2010
Homo sapiens
brenda
Ezzidi, I.; Mtiraoui, N.; Nemr, R.; Kacem, M.; Al-Khateeb, G.M.; Mahjoub, T.; Almawi, W.Y.
Variants within the calpain-10 gene and relationships with type 2 diabetes (T2DM) and T2DM-related traits among Tunisian Arabs
Diabetes Metab.
36
357-362
2010
Homo sapiens
brenda
Moreno-Luna, R.; Abrante, A.; Esteban, F.; Gonzalez-Moles, M.A.; Delgado-Rodriguez, M.; Saez, M.E.; Gonzalez-Perez, A.; Ramirez-Lorca, R.; Real, L.M.; Ruiz, A.
Calpain 10 gene and laryngeal cancer: A survival analysis
Head Neck
33
72-76
2011
Homo sapiens
brenda
Alsaraj, F.; OGorman, D.; McAteer, S.; McDermott, J.; Hawi, Z.; Sreenan, S.
Haplotype association of calpain 10 gene variants with type 2 diabetes mellitus in an Irish sample
Ir. J. Med. Sci.
179
269-272
2010
Homo sapiens
brenda
Unsal, T.; Konac, E.; Yesilkaya, E.; Yilmaz, A.; Bideci, A.; Ilke Onen, H.; Cinaz, P.; Menevse, A.
Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome
J. Assist. Reprod. Genet.
26
205-216
2009
Homo sapiens
brenda
Fong, P.Y.; Fesinmeyer, M.D.; White, E.; Farin, F.M.; Srinouanprachanh, S.; Afsharinejad, Z.; Mandelson, M.T.; Brentnall, T.A.; Barnett, M.J.; Goodman, G.E.; Austin, M.A.
Association of diabetes susceptibility gene calpain-10 with pancreatic cancer among smokers
J. Gastrointest. Cancer
41
203-208
2010
Homo sapiens
brenda
Bodhini, D.; Radha, V.; Ghosh, S.; Sanapala, K.R.; Majumder, P.P.; Rao, M.R.; Mohan, V.
Association of calpain 10 gene polymorphisms with type 2 diabetes mellitus in Southern Indians
Metab. Clin. Exp.
60
681-688
2011
Homo sapiens
brenda
Kurzawski, M.; Dziewanowski, K.; Kedzierska, K.; Gornik, W.; Banas, A.; Drozdzik, M.
Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus
Pharmacogenomics J.
10
120-125
2010
Homo sapiens
brenda
Ling, C.; Groop, L.; Guerra, S.D.; Lupi, R.
Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes
PLoS ONE
4
e6558
2009
Homo sapiens
brenda
Perez-Martinez, P.; Delgado-Lista, J.; Garcia-Rios, A.; Ferguson, J.F.; Gulseth, H.L.; Williams, C.M.; Karlstroem, B.; Kiec-Wilk, B.; Blaak, E.E.; Helal, O.; Malczewska-Malec, M.; Defoort, C.; Riserus, U.; Saris, W.H.; Lovegrove, J.A.; Drevon, C.A.; Roche, H.M.; Lopez-Miranda, J.
Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndrome
Am. J. Clin. Nutr.
93
1136-1141
2011
Homo sapiens
brenda
Panico, P.; Salazar, A.M.; Burns, A.L.; Ostrosky-Wegman, P.
Role of calpain-10 in the development of diabetes mellitus and its complications
Arch. Med. Res.
45
103-115
2014
Homo sapiens (Q9HC96)
brenda
da Silva, R.C.; de Alencar, N.A.; Alves, C.N.; Lameira, J.
Analysis of the structure of calpain-10 and its interaction with the protease inhibitor SNJ-1715
Comput. Biol. Med.
43
1334-1340
2013
Homo sapiens (Q9HC96), Homo sapiens
brenda
Seremwe, M.; Schnellmann, R.G.; Bollag, W.B.
Calpain-10 activity underlies angiotensin II-induced aldosterone production in an adrenal glomerulosa cell model
Endocrinology
156
2138-2149
2015
Homo sapiens (Q9HC96), Homo sapiens
brenda
Oladnabi, M.; Musante, L.; Larti, F.; Hu, H.; Abedini, S.S.; Wienker, T.; Ropers, H.H.; Kahrizi, K.; Najmabadi, H.
New evidence for the role of calpain 10 in autosomal recessive intellectual disability identification of two novel nonsense variants by exome sequencing in Iranian families
Arch. Iran Med.
18
179-184
2015
Homo sapiens (Q9HC96), Homo sapiens
brenda
Chaudhry, B.; Hanif, F.; Saboohi, K.
Molecular signatures of Calpain 10 isoforms sequences, envisage functional similarity and therapeutic potential
Pak. J. Pharm. Sci.
32
937-946
2019
Homo sapiens (Q9HC96)
brenda
3.4.22.B30 calpain 10
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
